Table 1:

Baseline and clinical characteristics of the study sample, stratified by the occurrence of MACEs^{^a}

Subjects	Total (n = 176)	Non-MACE Group (n = 142)	MACE Group (n = 34)	P Value
Age (yr)	69.3 (SD, 7.6)	69.3 (SD, 7.7)	69.2 (SD, 6.8)	.49
Median (IQR) (yr)	70 (64–75)	69 (64–75)	71 (66–75)
Male sex	156 (88.6)	126 (88.7)	30 (88.2)	.998
Body mass index (kg/m²)	24.5 (SD, 3.1)	24.5 (SD, 3.0)	24.4 (SD, 3.4)	.96
Risk factors
Diabetes mellitus	76 (43.2)	66 (46.5)	10 (29.4)	.096
Hypertension	126 (71.6)	101 (71.1)	25 (73.5)	.80
Dyslipidemia	96 (54.6)	77 (54.2)	19 (55.9)	.60
Current smoking	43 (24.4)	32 (22.5)	11 (32.4)	.42
Past smoking	68 (38.6)	56 (39.4)	12 (35.3)	.91
Atrial fibrillation	9 (5.1)	5 (3.5)	4 (11.8)	.001
Medical history
History of stroke^{^b}	56 (31.8)	44 (31.0)	12 (35.3)	.66
History of ACS^{^b}	30 (17.1)	21 (14.8)	9 (26.5)	.30
Antiplatelet	154 (87.5)	124 (87.3)	30 (88.2)	.72
Statins	142 (80.7)	115 (81.0)	27 (79.4)	.47

↵a Any stroke, ACS, or cardiovascular mortality. Continuous data are presented as means (SD) or median (IQR); categoric data are given as (No.) (%).
↵b Subjects with any stroke or ACS who had been diagnosed >6 months previously and successfully treated.